Catalyst Wire Dossier Catalyst Wire Dossier

ARRANON

nelarabine · Sandoz Inc
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ARRANON, covering 2009-12-15 to 2025-03-11. Get the full timeline:

Most recent: FDA Approved: ARRANON — Supplemental Application (Sandoz Inc)

See pricing